{
    "clinical_study": {
        "@rank": "9866", 
        "arm_group": [
            {
                "arm_group_label": "LiquiBand Flex", 
                "arm_group_type": "Active Comparator", 
                "description": "LiquiBand\u00ae Flex skin adhesive is indicated for topical application only, to hold closed easily approximated skin edges from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed trauma-induced lacerations.  It may be used in conjunction with, but not in place of deep dermal sutures."
            }, 
            {
                "arm_group_label": "Dermabond Advanced", 
                "arm_group_type": "Active Comparator", 
                "description": "Dermabond Advanced\u2122 adhesive is intended for topical application only, to hold closed easily approximated skin edges of wounds from surgical incisions, including incisions from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. Dermabond Advanced \u2122 adhesive may be used in conjunction with, but not in place of, deep dermal stitches."
            }, 
            {
                "arm_group_label": "Sutures (Prolene)", 
                "arm_group_type": "Active Comparator", 
                "description": "Prolene\u2122 Suture is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic and neurological procedures."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the cosmetic outcome, effectiveness, user and subject satisfaction, and safety\n      of LiquiBand\u00ae Flex in relation to DermaBond Advanced\u2122 and conventional sutures for the\n      topical closure of surgical wounds."
        }, 
        "brief_title": "LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Surgical Incisions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or Female aged 18 or older on day of enrollment\n\n          -  Scheduled for surgical procedure by a delegated study surgeon\n\n          -  Fresh surgical wound with evenly distributed tension over length of incision\n\n          -  Willing and able to sign informed consent\n\n          -  Agree to return for 2 week (+/- 7 days) and 3 month (90 days +/- 7 days)\n             post-procedure follow-up visit\n\n        Exclusion Criteria:\n\n          -  Known sensitivity to cyanoacrylates, formaldehyde or acetone products\n\n          -  Wounds in which incision edges are under high tension or not easily apposed (after\n             deep layer suture), or over joints (unless immobilized)\n\n          -  Wounds less than 15mm in length\n\n          -  Wounds in which haemostasis is not able to be achieved, eg, drain is placed or\n             Warfarin level >2.5 prior to surgery\n\n          -  Wounds in which deep closure could not be achieved\n\n          -  Surgical procedures involving mucus membranes or eyes\n\n          -  Mental incapacity, dementia, or inability to give informed consent\n\n          -  Pregnant or nursing\n\n          -  Disease related or pharmacologically immuno-compromised"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835405", 
            "org_study_id": "D-LBF001-05-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "LiquiBand Flex", 
                "intervention_name": "LiquiBand Flex", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Dermabond Advanced", 
                "intervention_name": "Dermabond Advanced", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sutures (Prolene)", 
                "intervention_name": "Sutures (Prolene)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 18, 2013", 
        "location": {
            "contact": {
                "email": "GARogers@nhs-healthlink.org", 
                "last_name": "Gary S Rogers, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Beverly", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01915"
                }, 
                "name": "Oncology Care Center, Beverly Hospital"
            }, 
            "investigator": {
                "last_name": "Gary S Rogers, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "GARogers@nhs-healthlink.org", 
            "last_name": "Gary S Rogers, MD", 
            "phone": "978-524-7933"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ]
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cosmesis to be evaluated by a panel of masked evaluators using a modified Hollander Wound Evaluation Scale", 
            "measure": "To compare cosmetic outcomes at follow up", 
            "safety_issue": "No", 
            "time_frame": "3 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835405"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Advanced Medical Solutions (Plymouth) Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Advanced Medical Solutions (Plymouth) Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}